11
person
Tanisha Carino
article
FasterCures Quarterly Newsletter
In this Issue
Responding to COVID-19—A Gamechanger for Everyone»
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
report
Consortia-pedia Framework Report
FasterCures initiated the Consortia-pedia project to better understand the breadth and scope of app
roaches that a wide range of consortia have adopted to bring together nontraditional partners with a shared R&D goa
+ Read More
report
Unlocking Intellectual Property: Principles for Responsible Negotiation
FasterCures convened a small Intellectual Property (IP) expert panel in July 2012 to develop a
set of guiding principles and points to consider that can serve as a useful tool for all parties
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
University-Foundation Relations: From Transactional to Transformative Partnerships
In biomedical research, both nonprofit disease foundations and academic research institutions are c
ommitted to translating research into effective therapies for patients.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
report
Cornerstones of Collaboration: Foundation-Led Partnerships to Accelerate R&D
Multi-stakeholder collaboration isn’t just the participation trophy of biomedical research and deve
lopment (R&D), a nice way to make sure everyone feels included.
+ Read More
article
Closing the Gap: How an Innovative Funding Model Is Delivering Hope
It is estimated that 25,000-50,000 Americans have a debilitating skin disorder called epidermol
ysis bullosa (EB).
+ Read More